Aschaffenburg, Germany

Ulrich Feil

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ulrich Feil: Innovator in Pharmaceutical Formulations

Introduction

Ulrich Feil is a notable inventor based in Aschaffenburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. With a total of 2 patents to his name, his work focuses on improving the stability and administration of pharmaceutical compounds.

Latest Patents

Feil's latest patents include an "Aqueous pharmaceutical formulation of tapentadol for oral administration." This innovative composition contains tapentadol or a physiologically acceptable salt thereof, designed for oral use. It boasts excellent storage stability without the need for high amounts of preservatives. Another significant patent is the "Semisolid aqueous pharmaceutical composition containing tapentadol." This formulation also contains tapentadol or a physiologically acceptable salt, showcasing his expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Ulrich Feil has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medication formulations.

Collaborations

Feil has collaborated with notable professionals in his field, including Ulrich Reinhold and Marc Schiller. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Ulrich Feil's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the industry. His patents reflect a deep understanding of medication stability and administration, marking him as a significant figure in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…